 | Apellis Pharmaceuticals, Inc. | |||
| NMS : APLS || Location: United States | ||||
$51.5-0.29 (-0.56%) |
2.62 M | 50.28 - 53.04 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 10.440 M |
| March 15, 2024 | 10.591 M |
| Feb. 29, 2024 | 10.064 M |
| Feb. 15, 2024 | 10.271 M |
| Jan. 31, 2024 | 10.669 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.70 | -0.73 | -4.27% |
| 09/30/2023 | -0.87 | -1.17 | -34.08% |
| 06/30/2023 | -1.35 | -1.02 | 24.40% |
| 03/31/2023 | -1.49 | -1.56 | -4.46% |
| 12/31/2022 | -1.60 | -1.50 | 6.20% |
APLS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 120.582M | Shares Float | 81.045M |
| Short Float | 10.440M | Market Cap | 6209.97M |
| Institution ownership | 95.99% | Insider ownership | 13.234% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.13 | Forward EPS | 1.20 |